ITTO20020331A0 - Formulazione farmaceutica somministrabile per via endonasale e suo impiego nel trattamento di sintomatologie rinitiche. - Google Patents

Formulazione farmaceutica somministrabile per via endonasale e suo impiego nel trattamento di sintomatologie rinitiche.

Info

Publication number
ITTO20020331A0
ITTO20020331A0 IT2002TO000331A ITTO20020331A ITTO20020331A0 IT TO20020331 A0 ITTO20020331 A0 IT TO20020331A0 IT 2002TO000331 A IT2002TO000331 A IT 2002TO000331A IT TO20020331 A ITTO20020331 A IT TO20020331A IT TO20020331 A0 ITTO20020331 A0 IT TO20020331A0
Authority
IT
Italy
Prior art keywords
administrable
treatment
pharmaceutical formulation
rhinitis symptoms
endonasal
Prior art date
Application number
IT2002TO000331A
Other languages
English (en)
Inventor
Jose Sebastian Franzone
Claudio Omini
Giuseppe Zuccari
Original Assignee
Medestea Res And Production S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medestea Res And Production S filed Critical Medestea Res And Production S
Priority to IT2002TO000331A priority Critical patent/ITTO20020331A1/it
Publication of ITTO20020331A0 publication Critical patent/ITTO20020331A0/it
Priority to PCT/EP2003/003832 priority patent/WO2003086429A1/en
Priority to AU2003229656A priority patent/AU2003229656A1/en
Publication of ITTO20020331A1 publication Critical patent/ITTO20020331A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT2002TO000331A 2002-04-16 2002-04-16 Formulazione farmaceutica somministrabile per via endonasale e suo impiego nel trattamento di sintomatologie rinitiche. ITTO20020331A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2002TO000331A ITTO20020331A1 (it) 2002-04-16 2002-04-16 Formulazione farmaceutica somministrabile per via endonasale e suo impiego nel trattamento di sintomatologie rinitiche.
PCT/EP2003/003832 WO2003086429A1 (en) 2002-04-16 2003-04-14 A pharmaceutical formulation for endonasal administration and its use in the treatment of rhinitic symptoms
AU2003229656A AU2003229656A1 (en) 2002-04-16 2003-04-14 A pharmaceutical formulation for endonasal administration and its use in the treatment of rhinitic symptoms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002TO000331A ITTO20020331A1 (it) 2002-04-16 2002-04-16 Formulazione farmaceutica somministrabile per via endonasale e suo impiego nel trattamento di sintomatologie rinitiche.

Publications (2)

Publication Number Publication Date
ITTO20020331A0 true ITTO20020331A0 (it) 2002-04-16
ITTO20020331A1 ITTO20020331A1 (it) 2003-10-16

Family

ID=27639010

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002TO000331A ITTO20020331A1 (it) 2002-04-16 2002-04-16 Formulazione farmaceutica somministrabile per via endonasale e suo impiego nel trattamento di sintomatologie rinitiche.

Country Status (3)

Country Link
AU (1) AU2003229656A1 (it)
IT (1) ITTO20020331A1 (it)
WO (1) WO2003086429A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3027070A4 (en) * 2013-08-02 2017-03-01 Sentiens, LLC Compositions and their use for smoking cessation and other treatments
CN103720875B (zh) * 2014-01-09 2015-12-30 冯萍 一种治疗慢性鼻炎的中药膏贴剂及其制备方法
WO2019236521A1 (en) * 2018-06-07 2019-12-12 Avanti Biosciences, Inc. Methods and formulations for intranasal administration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19627344A1 (de) * 1996-07-01 1998-01-08 Vitasyn Gmbh Entwicklung & Ver Therapeutisch wirksame bzw. gesundheitsfördernde Zubereitung aus definierten Polyphenolverbindungen
JP2000063262A (ja) * 1998-08-19 2000-02-29 Osaka Yakuhin Kenkyusho:Kk 抗菌性化粧料組成物
KR100377319B1 (ko) * 2000-02-29 2003-03-26 주식회사 네이쳐프러스 알레르기성 비염 치료용 에센셜 오일 조성물

Also Published As

Publication number Publication date
AU2003229656A1 (en) 2003-10-27
ITTO20020331A1 (it) 2003-10-16
WO2003086429A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
CY2016031I1 (el) Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων
GB0412753D0 (en) Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis
NO20044054L (no) Administrering av midler for behandling av betennelse
HK1089376A1 (en) Formulation for use in the prevention and treatment of carbohydrate induced ; diseases and conditions
ITMI20020078A0 (it) Dispositivo utilizzabile nel tratamento di affezzioni delle vie respiratorie
DK1342881T3 (da) Opskummet syrebehandlingsvæske
NO20055010D0 (no) Preparater inneholdende laktulose for behandling av potavirusinfeksjoner
DK1620113T3 (da) Topisk formulering af ivermectin til behandling af dermatologiske lidelser
IS8072A (is) Miðlar úr bak kólesteról flutningi í meðferð á kólesterólhækkun
NO20043313L (no) Anvendelse av COX-2 inhibitorer i kombinasjon med antivirale midler for behandling av Papilloma virus infeksjoner
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.
NL1025873A1 (nl) Doseringsvormen en wijzen van behandeling met vegfr-remmers.
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS7444A (is) Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
NO20055515D0 (no) 7-azaindoler og deres anvendelse som terapeutiske midler
NO20041024D0 (no) Anvendelse av BIBN4096 i kombinasjon med andre antimigrenelegemidler for behandling av migrene
SM200300009A (it) Composizione e suo uso terapeutico
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
ITTO20020331A0 (it) Formulazione farmaceutica somministrabile per via endonasale e suo impiego nel trattamento di sintomatologie rinitiche.
ITMI20021552A1 (it) Dispositivo per il trattamento di sangue in circuito extracorporeo
ITRM20050478A1 (it) Apparato per l'applicazione contemporanea della carbossiterapia e della mesoterapia.
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
IS8014A (is) Blöndur sem innihalda imídasópýridín og notkun þeirra í meðhöndlun maga- og garnabólgusjúkdóma
NO20053247L (no) Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.